Your browser doesn't support javascript.
loading
Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial.
Hanna, Nasser H; Kaiser, Rolf; Sullivan, Richard N; Aren, Osvaldo Rudy; Ahn, Myung-Ju; Tiangco, Beatrice; Voccia, Isabelle; Pawel, Joachim von; Kovcin, Vladimir; Agulnik, Jason; Gaschler-Markefski, Birgit; Barrueco, José; Sikken, Patricia; Schloss, Charles; Kim, Joo-Hang.
Afiliación
  • Hanna NH; Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indiana University, Indianapolis, IN, USA. Electronic address: nhanna@iupui.edu.
  • Kaiser R; Boehringer Ingelheim Pharmaceuticals GmbH & Co. KG, Biberach, Germany; Institute of Clinical Pharmacology, Georg-August-University Göttingen, Germany.
  • Sullivan RN; Department of Oncology, Auckland City Hospital, Auckland, New Zealand.
  • Aren OR; Instituto Nacional del Cáncer, Santiago, Chile.
  • Ahn MJ; Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Tiangco B; Internal Medicine, National Kidney and Transplant Institute, Quezon City, Philippines.
  • Voccia I; Boehringer Ingelheim (Canada) Ltd, Burlington, ON, Canada.
  • Pawel JV; Pneumology Clinic, Asklepios Fachkliniken, Gauting, Germany.
  • Kovcin V; Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia.
  • Agulnik J; Jewish General Hospital, Montréal, Québec, Canada.
  • Gaschler-Markefski B; Boehringer Ingelheim Pharmaceuticals GmbH & Co. KG, Biberach, Germany.
  • Barrueco J; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.
  • Sikken P; Boehringer Ingelheim Pharmaceuticals GmbH & Co. KG, Biberach, Germany.
  • Schloss C; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.
  • Kim JH; Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea.
Lung Cancer ; 102: 65-73, 2016 12.
Article en En | MEDLINE | ID: mdl-27987591
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles / 3_diarrhea / 4_diarrhoeal_infections / 6_other_respiratory_diseases / 6_sense_organ_diseases / 6_trachea_bronchus_lung_cancer Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Pemetrexed / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles / 3_diarrhea / 4_diarrhoeal_infections / 6_other_respiratory_diseases / 6_sense_organ_diseases / 6_trachea_bronchus_lung_cancer Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Pemetrexed / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article